Boston Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-31,855
Closed -$524K 657
2017
Q2
$524K Sell
31,855
-800
-2% -$13.2K 0.01% 486
2017
Q1
$468K Buy
32,655
+2,695
+9% +$38.6K 0.01% 481
2016
Q4
$414K Buy
29,960
+7,980
+36% +$110K 0.01% 515
2016
Q3
$397K Buy
+21,980
New +$397K 0.01% 558